Related by context. Frequent words. (Click for all words.) 84 Marketing Authorization Application MAA 75 Biologics License Application 75 Biologics License Application BLA 70 sBLA 67 New Drug Application 67 European Medicines Evaluation 67 sNDA 66 Rhucin 65 ATryn R 65 Ceplene 64 BENLYSTA 64 Orphan Drug designation 64 Approvable Letter 63 Orphan Drug Designation 63 Pixantrone 63 Ventavis 63 Phase III Trial 62 Torisel 62 NDA submission 62 Investigational Device Exemption IDE 62 Ceftobiprole 62 L MTP PE 62 INDs 62 Cimzia ® 62 Cladribine Tablets 62 TORISEL 61 Complete Response letter 61 Satraplatin 61 Neupro ® 61 Investigational 61 Priority Review 61 ADVEXIN 61 Phase IIa trial 61 Ceplene R 60 European Medicines Agency 60 eltrombopag 60 Renvela 60 Naglazyme 60 Bronchitol 60 Phase III clinical trials 60 Vasovist 60 Esbriet 60 Santhera 60 Phase III clinical 60 Amitiza 60 Orphan Drug 59 Rifaximin 59 Fast Track designation 59 Mozobil 59 Phase III pivotal 59 CHMP 59 Taxotere ® 59 StaphVAX 59 Phase 2b trial 59 ceftobiprole 59 Drug Application 59 vilazodone 59 pivotal Phase III 59 velaglucerase alfa 59 Dyloject 58 clofarabine 58 RELISTOR 58 VPRIV 58 pralatrexate 58 Clolar 58 Cimzia 58 Entereg 58 NUVIGIL 58 bifeprunox 58 PDUFA date 58 Actemra 58 Antegren 58 FavId 58 Treanda 58 Complete Response Letter 58 FOLOTYN 58 Qutenza 58 Taxotere R 58 cutaneous T cell 58 Phase IIb trial 58 CoFactor 58 ONSOLIS 58 Kuvan 58 FOSRENOL 58 Topical Interferon Alpha 2b 58 Phase Ib 58 BYDUREON 58 SEROQUEL XR 57 TREANDA 57 ATRIPLA 57 cladribine 57 PhosLo 57 BAY #-# 57 Marqibo 57 Ceplene ® 57 Aridol 57 Horizant 57 ambrisentan 57 Phase IIa 57 oritavancin 57 Phase III trials